جستجوی استاد راهنمای دانشگاهی

Jude M. Phillipمشاهده پروفایل

استادیار

• Aging
• Mechanobiology
• Cancer Biology
• +۵ مورد دیگر

Jude M. Phillip, PhD, is an Assistant Professor in the Departments of Biomedical Engineering and Chemical and Biomolecular Engineering at Johns Hopkins University. His research integrates engineering principles with aging and cancer biology to develop cell-based biomarkers and mechanistic insights into age-related diseases. He leads the Phillip tiME Lab, which focuses on aging dynamics, tumor microenvironment interactions, and translational technologies. Education : PhD, Chemical and Biomolecular Engineering, Johns Hopkins University, 2015 Postdoctoral Research, Melnick/Cerchietti Labs, Weill Cornell Medicine, 2016-2020 B.Eng, Chemical Engineering, City College of New York, 2010 Research Interests : Dr. Phillip’s work spans aging mechanisms, cancer biology, and mechanobiology. Key areas include: Cell-based biomarkers for aging and disease Scale-dependent aging pathways Lymphoma tumor-immune microenvironment (tiME) Single-cell profiling of senescence subtypes ECM mechanoregulation of stem cell fate His lab employs longitudinal cell profiling, data science, and clinical measures to bridge biological aging research with translational medicine. Recent Highlights : 2025: NIH R35 MIRA Award for lymphoma microenvironment research 2024: Johns Hopkins Catalyst Award for aging biomarker studies 2023: AFAR-Glenn Foundation Award for senescence subtype classification Lab & Collaborations : The Phillip Lab collaborates with the Institute for NanoBioTechnology and maintains a living patient-derived tumor biorepository for lymphoma studies. Current projects include ovarian aging organoid models and immune-mechanical interactions in cancer progression.

Grant E. Lattin Jr.مشاهده پروفایل

دانشیار

• Abdominal Imaging
• Women's Imaging
• Cancer Imaging
• +۵ مورد دیگر

Grant E. Lattin Jr. serves as Associate Professor in Radiology (primary) and Pathology (secondary) at Uniformed Services University of the Health Sciences, concurrently directing the National Capital Consortium Diagnostic Radiology Residency and Body Imaging Fellowship at Walter Reed National Military Medical Center. His clinical expertise spans abdominal, genitourinary, gastrointestinal, forensic, tropical, and women's imaging within military medical contexts. Dr. Lattin's educational foundation includes: Bachelor of Arts in Japanese, Brigham Young University (1996-1998) MD from Uniformed Services University (1999-2003) General Surgery Internship, David Grant USAF Medical Center (2003-2004) Diagnostic Radiology Residency, David Grant USAF Medical Center (2004-2008) Visiting Scientist in Gastrointestinal Radiology, Armed Forces Institute of Pathology (2009-2010) His research centers on radiologic-pathologic correlation across abdominal imaging subspecialties, with significant contributions to medical education and quality improvement in diagnostic radiology. Military-specific applications in forensic and tropical imaging represent unique dimensions of his work. Recent publications (2013-2017) demonstrate consistent focus on correlating imaging findings with pathology across diverse anatomical sites including renal, genitourinary, adrenal, splenic, and male breast pathologies. These works published in Radiographics establish Dr. Lattin as an authority in bridging diagnostic imaging with pathological confirmation. No specific scientific awards are documented in available sources. As Program Director for both residency and fellowship programs, Dr. Lattin mentors radiology trainees while leading curriculum development at USU. His educational innovations include integrated radiology components across lecture formats and small-group learning, shaping military radiology education standards. Dr. Lattin maintains leadership roles at the American Institute for Radiologic Pathology as Section Chief for Genitourinary Radiology while directing radiology education initiatives at Walter Reed National Military Medical Center, fostering interdisciplinary collaboration between radiologists and pathologists.

Rui Guoمشاهده پروفایل

استادیار

• Epstein-Barr Virus (EBV) Pathogenesis
• Viral Oncology
• Cancer Metabolism
• +۵ مورد دیگر

Rui Guo is an Assistant Professor at Tufts University School of Medicine, affiliated with the Department of Molecular Biology and Microbiology. Their research focuses on Epstein-Barr Virus (EBV) pathogenesis, particularly its role in cancers like Burkitt lymphoma and mechanisms for developing targeted therapies. Doctor of Philosophy (2018), Kansas State University Master of Science (2013) and Bachelor of Science (2010), Yangzhou University Research interests include EBV-driven metabolic vulnerabilities in B-cells, with a focus on methyl group metabolism, mitochondrial remodeling, and lipid dynamics. Their work aims to improve cancer treatments by targeting viral dependencies. Recent publications highlight discoveries in EBV's manipulation of cardiolipin synthesis , methionine metabolism , and lysosomal iron reduction in Burkitt lymphoma. Techniques include transcriptomics , metabolomics , and CRISPR/Cas9 screening . Scientific recognition includes: National Institutes of Health Grant (2022-2026) for Epstein-Barr Virus epigenetic research

• Hematology
• Medical Oncology
• Lymphoma Research
• +۳ مورد دیگر

Lindsey A. Fitzgerald, MD, is a clinical faculty member at the University of Utah School of Medicine and treats veterans at the George E. Wahlen Department of Veterans Affairs Medical Center. Her academic rank is Assistant Professor in the Department of Internal Medicine, specializing in Hematology and Hematologic Malignancies. Dr. Fitzgerald earned her undergraduate degree in Geography and Biology from Dartmouth College, followed by her MD from Tufts University School of Medicine. She completed residency and fellowship training at the University of Utah, where she is board-certified in Hematology and Medical Oncology. Research activities focus on aggressive non-Hodgkin lymphomas , CAR T-cell therapy outcomes , and geographic treatment variations . Key interests include elderly patient management, secondary malignancies post-immunotherapy, and epidemiological disparities in lymphoma survival. Recent publications analyze CAR T-cell therapy applications in double-hit lymphomas, race-based outcome disparities , and post-transplant maintenance strategies for Hodgkin lymphoma. Collaborative work spans multicenter studies with institutions like ASH and AVAHO.

• Lymphoma Diagnosis
• Extranodal Lymphomas
• Pathologic Features of Hematologic Diseases
• +۳ مورد دیگر

Judith Ferry, MD, is the Director of Hematopathology at Massachusetts General Hospital and a Professor of Pathology at Harvard Medical School. She specializes in lymphoma diagnosis, subclassification, and extranodal hematologic diseases. Education: MD from New York University Her research focuses on integrating morphology, immunophenotype, and genetic features to improve hematologic disease classification. She has published extensively on extranodal lymphomas, including a textbook on the subject. Dr. Ferry's clinical program reviews ~8,900 specimens annually, including bone marrow, lymph nodes, and extranodal sites, using flow cytometry and molecular testing. She leads multidisciplinary conferences with Hematology/Oncology teams and directs an ACGME-accredited Hematopathology Fellowship program. Her work emphasizes: Extranodal vs. nodal lymphoma differences Risk factor analysis for lymphoma development Training future hematopathology leaders Advanced diagnostic integration techniques

Leo I Gordonمشاهده پروفایل

استاد

• Lymphoma Research
• Cancer Biology
• Translational Oncology
• +۴ مورد دیگر

Leo I Gordon, MD serves as the Abby and John Friend Professor of Oncology Research and Professor of Medicine (Hematology and Oncology) at Northwestern University's Feinberg School of Medicine. He maintains active clinical practice at Northwestern Memorial Hospital and holds affiliations with the Robert H. Lurie Comprehensive Cancer Center and Simpson Querrey Institute for Epigenetics. Education: MD: University of Cincinnati (1973) Intern: University of Chicago Hospitals, Medicine (1974) Resident: University of Chicago Hospitals, Medicine (1976) Fellow: University of Minnesota Hospital, Hematology (1978) Fellow: University of Chicago Hospitals, Hematology-Oncology (1979) Research Focus: Dr. Gordon's translational program targets lymphoma through dual pathways: basic research on cholesterol efflux pumps, NRF2 resistance mechanisms, and nanoparticle drug delivery systems; and clinical investigation of CAR-T therapies, novel biologics, and stem cell transplantation. His team pioneered bioinspired lipoprotein gold nanoparticles to induce ferroptotic cell death in cholesterol-addicted malignancies. Publication Trends: 2025 publications reveal intensified focus on metabolic targeting (AML ferroptosis induction), advanced imaging for lymphoma prognostication, CAR-T applications for non-transplant candidates, and checkpoint inhibitor combinations in first-line DLBCL therapy—demonstrating continuous innovation from bench to bedside. Scientific Recognition: Best Doctors in America, Castle Connolly (2025) Best Doctors in America, Castle Connolly (2024) Alumni Achievement Award, University of Cincinnatti (2023) Lymphoma Research Foundation Partners In Hope Award (2023) Mecklenberg Distinguished Physician Award, Northwestern Medicine (2022) Hope Award, Lymphoma Research Foundation (2007) Jonas Lectureship in Lymphoma, Washington University (2005) Leadership & Funding: Current Scientific Advisory Board Member (Lymphoma Research Foundation, 2005-present) with prior chairmanship (2015-2017). Research funded through ECOG, SPORE programs, and pharmaceutical collaborations with editorial roles in Clinical Cancer Research (2010-2015) and Journal of Clinical Oncology (2007-2010). Research Ecosystem: Directs collaborative projects across Northwestern's Center of Cancer Nanotechnology Excellence and Department of Urology, leveraging nanotechnology platforms developed with Dr. Colby Shad Thaxton to target lymphoma signaling pathways.

• Hematology
• Lymphoma
• Immunology
• +۳ مورد دیگر

Dr. Francine Foss is a Professor of Medicine (Hematology) and Dermatology at Yale School of Medicine , where she serves as Director of the Multidisciplinary T-cell Lymphoma Program and Scientific Leader of the Lymphoma CRT at Yale Cancer Center. She is also a Co-Director of the Cutaneous Lymphoma Program with Dr. Michael Girardi and President of the United States Cutaneous Lymphoma Consortium . Dr. Foss specializes in the development and testing of therapies for T-cell lymphomas, with a focus on: FDA-approved biologic drugs (e.g., Interleukin-2-Diphtheria toxin fusion protein) Stem cell transplantation and graft-versus-host disease reduction National T-cell lymphoma registry (COMPLETE Registry) and international collaborations Molecular target identification in T-cell lymphomas Novel small molecule therapeutic development (PITCH program) Her research has led to NCI-sponsored clinical trials and global PETAL Consortium studies on relapsed/refractory lymphomas. She has published extensively on: Spatial multiomics in angioimmunoblastic lymphoma Prognostic scoring systems for T/NK-cell lymphomas Vaccine response in post-transplant patients Biopsy practice standardization for cutaneous lymphomas Dr. Foss collaborates with laboratories at Yale and leads the Smilow Cancer Center's T-cell Lymphoma clinical team , attracting global patients. Her work bridges clinical practice and translational research.

• Hematology
• Transfusion Medicine
• Sickle Cell Disease
• +۴ مورد دیگر

Raisa Balbuena-Merle, MD, MHS, is an Assistant Professor in the Department of Laboratory Medicine at Yale School of Medicine. She holds affiliations with the Apheresis/Transfusion Service, Blood Bank, and Hamburg House. Her academic background includes an MD from the University of Puerto Rico School of Medicine (2012), followed by residency in Anatomic & Clinical Pathology at the same institution, and fellowships in Hematopathology and Transfusion Medicine at Yale University. Her research focuses on immunohematology, transfusion medicine, and sickle cell disease, with an emphasis on red blood cell alloimmunization mechanisms, molecular diagnostics in hematologic malignancies, and clinical informatics. Notable contributions include studies on lymphoma subtyping, electronic health record integration for blood smear analysis (PROSER tool), and the immunologic underpinnings of SARS-CoV-2 severity in sickle cell disease. Key Research Themes: Alloimmunization dynamics in pregnancy and transfusion contexts Molecular pathogenesis of hematologic malignancies Clinical informatics applications in pathology Dr. Balbuena-Merle has received the Jatlow Award (2019) from Yale School of Medicine. She actively collaborates with researchers like Christopher Tormey, Alexa Siddon, and Jeanne Hendrickson on projects spanning transfusion safety, immune profiling in sickle cell disease, and diagnostic tool development. Her work bridges clinical pathology with translational research, emphasizing patient-centered innovations in diagnostics and transfusion medicine.

Andrés José María Ferreriمشاهده پروفایل

استاد

• Lymphoma Research
• Medical Oncology
• Extranodal Lymphomas
• +۳ مورد دیگر

Andrés José María Ferreri is a Senior Physician in the Lymphoma Unit at IRCCS Ospedale San Raffaele and a Contract Professor of Oncology at Università Vita-Salute San Raffaele. Born in Argentina, he holds medical degrees from the University of Buenos Aires (1985), University of Parma (1992), and a specialization in Medical Oncology from the University of Milan (2005). His research focuses on lymphoma etiology, translational studies, and clinical trials, particularly in extranodal and brain lymphomas. He pioneered antibiotic therapy for Chlamydia psittaci-associated orbital lymphoma. As head of the Lymphoma Unit, he developed global treatment guidelines for brain lymphoma and founded the International Extranodal Lymphoma Study Group and the Italian Lymphoma Foundation. He is affiliated with the European School of Oncology and has authored numerous peer-reviewed articles and textbook chapters in oncology.

• Hematopathology
• Clinical Pathology
• Myelodysplastic Syndromes
• +۵ مورد دیگر

Dariusz R Stachurski is an Associate Professor of Pathology and Laboratory Medicine at the Warren Alpert School of Medicine, Brown University. He serves as System Director of Brown University Health Clinical Laboratories, Chairman of the Pathology Department at Newport Hospital, and Laboratory Medical Director at Eleanor Slater Hospital. Education: MD (1999) from Poznan University of Medical Sciences, BA in Zoology & Premedicine (1992) from George Washington University Dr. Stachurski specializes in hematopathology with a focus on myelodysplastic syndromes , benign hematology , and transfusion medicine . His work emphasizes clinical laboratory operations , quality management , and diagnostic pattern recognition . Recent publications analyze hematologic malignancies , flow cytometry applications , and cytogenetic abnormalities . Key trends: HIV-associated lymphomas, ALK-positive lymphomas, myelodysplastic syndromes, PNH detection, and diagnostic pitfalls Scientific affiliations include: American Medical Association United States and Canadian Academy of Pathology College of American Pathologists Rhode Island Society of Pathology (Past President & Treasurer/Secretary) American Society of Hematology Dr. Stachurski has held leadership roles including: Chairman of Rhode Island Delegation (College of American Pathologists, 2016) President of Rhode Island Blood Center (2014) Laboratory Medical Director positions at multiple institutions

• Hematopathology
• Genetics
• Mechanisms of Cancer
• +۴ مورد دیگر

Michael A Linden is a Professor at the Laboratory Medicine and Pathology department of the University of Minnesota . He specializes in Hematopathology , Genetics , and Mechanisms of Cancer , with a focus on Plasma Cell Neoplasms , Multiple Myeloma , and Immunophenotyping . Research Interests: His work spans diagnostic challenges in plasma cell neoplasms, immune modulation post-transplantation, canine lymphoma prevention, and stress-immune interactions. Projects: Current projects include CD83-targeted therapies , Canine Lymphoma Early Detection , and clinical trials for Iberdomide in Multiple Myeloma . Article Trends: Recent publications emphasize Ki-67 in Follicular Lymphoma , Flow Cytometry applications , and cross-species oncology comparisons . Collaborations: Active in the Alliance for Clinical Trials in Oncology and partnerships with Morris Animal Foundation , NIH , and Health Research, Inc.

Rahul Gosainمشاهده پروفایل

استادیار بالینی

• Hematology
• Medical Oncology
• Cancer Immunotherapy
• +۷ مورد دیگر

Rahul Gosain, M.D., is a Clinical Assistant Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He practices at the Wilmot Cancer Institute and is part of UR Medicine's Faculty Group, which includes over 900 providers. MD, University of Medicine & Health Sciences (2012) MBA, Johns Hopkins University (2024) Dr. Gosain's research focuses on cancer immunotherapy, melanoma, lung cancer, and survivorship care. His work includes studies on tumor microenvironments, chemotherapy complications, and patient-centered outcomes in oncology. Recent publications examine HPV-related head and neck cancers, thrombotic microangiopathy treatment, and cancer care disparities. His scientific awards include Chief Fellow, "Best Fellow" Award, and multiple Outstanding Resident/Performance recognitions. Dr. Gosain has contributed to books on lung cancer and global cancer care, and his clinical work spans hematology, medical oncology, and critical care complications in cancer patients.

Sharon Germansمشاهده پروفایل

استادیار

• Hematopathology
• Flow Cytometry
• Leukemia/Lymphoma Research
• +۳ مورد دیگر

Dr. Sharon Germans is an Assistant Professor in the Department of Hematopathology at the University of Texas Southwestern. Her work focuses on hematologic malignancies, particularly leukemia/lymphoma and multiple myeloma, with expertise in flow cytometry and genomic analysis. Education: Medical school and residency in India, followed by residency in Anatomic & Clinical Pathology and Hematopathology fellowship at UTSW. Her research integrates clinical pathology with molecular diagnostics, addressing diagnostic challenges and therapeutic implications in mixed phenotype acute leukemias (MPAL), NPM1 mutations, and drug response mechanisms. Recent studies emphasize genomic profiling of MPAL, CRLF2-rearranged leukemias, and RUNX1 mutations, alongside therapeutic impacts of drugs like daratumumab. She has contributed to understanding genotype-phenotype discordance in acute leukemias and improving diagnostic accuracy through immunohistochemical and flow cytometric techniques. No scientific awards are listed, though her prolific publication rate suggests active engagement with the field. Grant activity and lab affiliations are not detailed in the provided text.

Min Yiمشاهده پروفایل

استادیار

• Internal Medicine
• Hospital Medicine
• Hematology
• +۳ مورد دیگر

Min Yi, D.O., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hospital Medicine. He graduated from the University of North Texas Health Science Center with a Doctor of Osteopathic Medicine degree and completed his internal medicine residency at Mount Sinai Morningside-West in New York. Certified by the American Board of Internal Medicine since 2009, his clinical focus is on hospital medicine. Dr. Yi's research spans two distinct areas: hematologic malignancies and battery safety technology. In medicine, his work includes genomic analysis of acute leukemias, myeloma microenvironment studies, and molecular diagnostics. In engineering, he investigates thermal runaway prevention in lithium-ion batteries using phase change materials and flame-retardant composites. His articles bridge oncology (e.g., NPM1 mutation correlations in AML) and energy storage safety (e.g., aerogel-based thermal management systems). Professional memberships include the Dallas County Medical Society, Society of Hospital Medicine, and American Medical Association. His recent work emphasizes translational research, combining clinical observations with material science innovations to address both medical and energy sector challenges.

Michael Bayerlمشاهده پروفایل

استاد

• Lymphoma
• Hematopathology
• Molecular Pathology
• +۳ مورد دیگر

Dr. Michael Bayerl is a Professor in the Department of Pathology and Laboratory Medicine , specializing in Anatomic Pathology . His research focuses on lymphomas, hematopathology, and the interplay between viral infections and malignancies, particularly Epstein-Barr virus-positive lymphomas. He has published extensively on rare lymphoproliferative diseases and their diagnostic challenges. Recent research trends in his work include: Molecular profiling of B-cell lymphomas (2023) Immunopathogenesis of graft-versus-leukemia models (2022) Viral oncology in mucosa-associated lymphoid tissue (2022) Cutaneous lymphoma dissemination (2025) Diagnostic criteria for hemophagocytic syndromes (2022) His work contributes to the UN Sustainable Development Goals for health and well-being (SDG 3) through advancements in lymphoma diagnostics and treatment models.